CVS Health CEO surrenders shares for tax withholding

CVS Health Corp director and President & CEO J. David Joyner reported a routine tax-withholding transaction.

Rhea-AI Filing Summary

CVS Health Corp director and President & CEO J. David Joyner reported a routine tax-withholding transaction. On February 28, 2026, he surrendered 1,944 shares of common stock at $79.90 per share to cover taxes due on a vested restricted stock unit award. After this, he directly held 49,996 common shares and 74,534 RSU-based common stock equivalents.

Insights

Insider transactions analyst

Routine tax-withholding share surrender; not an open-market sale.

J. David Joyner, President, CEO and director of CVS Health Corp, reported a Form 4 showing a code F transaction on February 28, 2026. He surrendered 1,944 shares of common stock at $79.90 per share to satisfy withholding taxes on a vested restricted stock unit award.

Code F transactions are typically administrative and differ from discretionary buying or selling on the open market. Following this withholding-related disposition, his direct holdings stood at 49,996 common shares and 74,534 shares tied to restricted stock units, indicating continued substantial equity exposure.

Insider Trade Summary

Exercise Price or Tax Liability: 1,944 shares

Exercise Price or Tax Liability 2 txns

Insider Joyner J. David

Role President and CEO

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	1,944	$79.90	$155K
holding	Common Stock (RSUs)	--	--	--

Holdings After Transaction: Common Stock — 49,996 shares (Direct); Common Stock (RSUs) — 74,534 shares (Direct)

Footnotes (1)

1. F1. Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CVS (CVS) report for J. David Joyner?

CVS Health Corp reported that J. David Joyner surrendered 1,944 common shares at $79.90 per share on February 28, 2026. This was a tax-withholding disposition related to the vesting and settlement of a restricted stock unit award, not an open-market sale.

Was the CVS (CVS) Form 4 transaction an open-market sale by the CEO?

No, the Form 4 shows a code F tax-withholding disposition, not an open-market sale. J. David Joyner surrendered 1,944 shares to pay withholding taxes due upon vesting and settlement of restricted stock units, an administrative step commonly tied to equity compensation.

How many CVS common shares does J. David Joyner hold after this Form 4?

After the reported tax-withholding disposition, J. David Joyner directly holds 49,996 shares of CVS common stock. The filing also shows 74,534 shares of common stock underlying restricted stock units, reflecting additional equity interests linked to his compensation arrangements at the company.

What does the 74,534 CVS common stock (RSUs) figure represent?

The 74,534 figure represents common stock underlying restricted stock units held by J. David Joyner after the transaction. These units typically convert into common shares upon vesting and settlement, separate from his 49,996 directly held common shares, and form part of his long-term equity compensation.

What does Form 4 transaction code F mean for CVS (CVS) insiders?

Transaction code F on Form 4 indicates payment of exercise price or tax liability by delivering securities. For CVS, J. David Joyner used 1,944 shares to cover withholding taxes on restricted stock units, reflecting an administrative disposition rather than a voluntary market sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/02/2026 - 05:46 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Joyner J. David

(Last) (First) (Middle)

ONE CVS DRIVE

(Street)

WOONSOCKET RI 02895

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CVS HEALTH Corp [ CVS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/28/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/28/2026		F		1,944(1)	D	$79.9	49,996	D
Common Stock (RSUs)								74,534	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award.

	/s/ J. David Joyner	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.